<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00462020</url>
  </required_header>
  <id_info>
    <org_study_id>07 02 031</org_study_id>
    <nct_id>NCT00462020</nct_id>
  </id_info>
  <brief_title>Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis</brief_title>
  <official_title>Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Mercy Hospital Kansas City</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Mercy Hospital Kansas City</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to scientifically evaluate two different management strategies
      for perforated appendicitis.

      The hypothesis is that early discharge with oral antibiotic therapy may result in a dramatic
      decrease in medical care expenses for the patient.

      The primary outcome variable between the two strategies is abscess rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a single institution, prospective, randomized clinical trial involving patients
      who present to the hospital with perforated appendicitis. This will be a definitive study.

      Power calculation was based on abscess rate in the previous prospective, randomized study we
      just finished. Our current rate is 18%, or just under one-fifth of the patients. A doubling
      of this rate to 36% would place just over one third of the patients at risk which would be
      unacceptable. Using a delta of 0.18 with alpha of 0.05 and power of 0.8, the sample size is
      74 patients in each arm. Therefore we will anticipate enrolling 150.

      Subjects will be those children who undergo a laparoscopic appendectomy as part of their
      routine care.

      Perforation will be defined as an identifiable hole in the appendix or stool in the abdomen.

      The control group will receive current standard care: ceftriaxone 50mg/kg once a day (maximum
      dose = 2 grams) and metronidazole 30mg/kg once a day (maximum dose = 1 gram) with once a day
      dosing for both. The length of antibiotic therapy will be a minimum of 5 days. At that time,
      if they have been afebrile for at least 24 hours, a white blood cell (WBC) count will be
      obtained, and if that is within normal limits, the antibiotics will be discontinued and the
      patient will be discharged. If the WBC is elevated, they will receive another 2 days before
      recheck, if still elevated, they receive another 3 days and a CT is obtained. If, after 5
      days of therapy, the patient remains febrile, therapy will continue until afebrile before a
      WBC check is performed. This is all our current standard management.

      The experimental group will receive the same combination of antibiotics while in the
      hospital. When the patient is tolerating a regular diet, on oral pain medication and has been
      afebrile for over 12 hours, they will be discharged on oral antibiotics to complete a course
      of 7 days. The home antibiotic regimen will be ampicillin/clavulanic acid (Augmentin®).
      Augmentin® dose will be 40mg/kg twice a day. They will be asked to bring their pill
      containers with them to clinic where we will quantify medication compliance.

      Given the purpose of this study is the comparison of oral antibiotics to intravenous
      antibiotics, an allergy to one of the above medications will not be considered an exclusion
      criteria. In such cases the patient will be treated with an alternative that offers the same
      spectrum of coverage, but will be included in the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Abscess After Appendectomy</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of Stay, Charges, Adverse Events</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Perforated Appendicitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 days of IV antibiotics after appendectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5 days of IV antibiotics (ceftriaxone and metronidazole)</intervention_name>
    <description>5 days of IV antibiotics (ceftriaxone and metronidazole once a day dosing)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Home with oral antibiotics when eating (ampicillin/clavulanic acid)</intervention_name>
    <description>Augmentin 40mg/kg BID when tolerating POs to complete 7 days total</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Identifiable hole in the appendix or stool in the abdomen at the time of appendectomy

        Exclusion Criteria:

          -  Known immune deficiency

          -  Abscess identified on pre-op imaging

          -  Another condition affecting surgical decision making or recovery (e.g. hemophilia,
             severe cardiac or respiratory co-morbidities).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shawn D St. Peter</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Mercy Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2007</study_first_submitted>
  <study_first_submitted_qc>April 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2007</study_first_posted>
  <results_first_submitted>December 12, 2011</results_first_submitted>
  <results_first_submitted_qc>December 12, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 16, 2012</results_first_posted>
  <last_update_submitted>December 12, 2011</last_update_submitted>
  <last_update_submitted_qc>December 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Mercy Hospital Kansas City</investigator_affiliation>
    <investigator_full_name>Shawn St. Peter</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>appendicitis, perforation, abscess, treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Ceftriaxone</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>All patients with perforated appendicitis were recruited for this study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>IV Only</title>
          <description>5 days of IV antibiotics after appendectomy</description>
        </group>
        <group group_id="P2">
          <title>IV and Oral Abx</title>
          <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IV Only</title>
          <description>5 days of IV antibiotics after appendectomy</description>
        </group>
        <group group_id="B2">
          <title>IV and Oral Abx</title>
          <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.7" spread="4.2"/>
                    <measurement group_id="B2" value="10.1" spread="4.6"/>
                    <measurement group_id="B3" value="9.9" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Abscess After Appendectomy</title>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Only</title>
            <description>5 days of IV antibiotics after appendectomy</description>
          </group>
          <group group_id="O2">
            <title>IV and Oral Abx</title>
            <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
          </group>
        </group_list>
        <measure>
          <title>Abscess After Appendectomy</title>
          <units>number of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay, Charges, Adverse Events</title>
        <time_frame>1 month</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>IV Only</title>
          <description>5 days of IV antibiotics after appendectomy</description>
        </group>
        <group group_id="E2">
          <title>IV and Oral Abx</title>
          <description>home on oral antibiotics to complete 7 days of treatment when tolerating PO's</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Shawn D. St. Peter, MD</name_or_title>
      <organization>Children's Mercy Hospital</organization>
      <phone>816-983-6479</phone>
      <email>sspeter@cmh.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

